Deep Learning-Assisted Accuracy Improvement in Bladder Cancer Staging of Spectrum-Aided Visual Enhanced Cystoscopy Images.

Recent statistics reported by the World Health Organization and the International Agency for Research on Cancer indicate that the global incidence of bladder cancer has continued to increase in recent years, particularly in industrialized countries. Therefore, the timely diagnosis of early-stage bladder cancer is of great clinical importance for improving patient prognosis and treatment outcomes. In this context, computational optical sensing frameworks that integrate Spectrum-Aided Visual Enhancer (SAVE) technology with cystoscopy have attracted significant attention to overcome the limitations of conventional visual data interpretation. In this study, an AI-driven optical biosensing framework was evaluated using 1372 white-light cystoscopy (WLC) images of bladder cancer (RGB-WLC) collected in collaboration with Chung Shan Medical University Hospital. Hyperspectral conversion technology was applied to extract precise spectral information from the white-light images. Subsequently, dimensionality reduction was performed based on the characteristic wavelengths of narrow-band imaging cystoscopy at 415 nm and 540 nm to generate hyperspectral reconstructed narrow-band images. The images were categorized into Ta stage (Ta), above T1 stage (Above T1), and four additional classes. The dataset was divided into training and testing sets to establish both a standard white-light cystoscopy model (RGB-WLC) and an advanced hyperspectral biosensing model utilizing the YOLOv8 architecture for enhanced pattern recognition. Model performance was evaluated using sensitivity,